Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 25, 2025	May 26, 2024	May 28, 2023	May 29, 2022	May 30, 2021
Cash & Equivalents	8.27	8.46	19.09	0.99	1.16
Cash & Short-Term Investments	8.27	8.46	19.09	0.99	1.16
Cash Growth	-2.33%	-55.67%	1826.44%	-14.49%	221.94%
Accounts Receivable	35.67	31.15	29.02	38.31	41.43
Receivables	43.67	31.15	29.02	38.31	41.43
Inventory	32.29	39.98	40.84	36	63.08
Prepaid Expenses	1.45	1.44	4.02	1.05	4.54
Other Current Assets	-	-	0.9	40.31	38.12
Total Current Assets	85.68	81.03	93.88	116.67	148.32
Property, Plant & Equipment	123.48	126.36	138.67	124.22	137.38
Goodwill	13.88	13.88	13.88	13.88	33.92
Other Intangible Assets	4.2	4.2	4.2	4.2	25.63
Long-Term Deferred Charges	-	-	1.4	-	-
Other Long-Term Assets	12.1	28.48	1.52	15.73	157.67
Total Assets	239.34	253.96	253.55	274.7	502.92
Accounts Payable	8.22	16.33	22.1	12.95	16.3
Accrued Expenses	8.06	9.67	11.29	15.42	11.71
Short-Term Debt	-	-	-	40	29
Current Portion of Long-Term Debt	3.44	0.94	0.58	98.18	-
Current Portion of Leases	0.39	3.96	1.27	4.37	1.6
Current Unearned Revenue	3.42	2.11	4.05	0.92	0.64
Other Current Liabilities	6.66	5.85	-	4.74	42.64
Total Current Liabilities	30.18	38.87	39.29	176.58	101.89
Long-Term Debt	127	123.73	101.07	-	166.64
Long-Term Leases	-	-	9.71	7.66	20.36
Long-Term Unearned Revenue	-	-	2.94	-	-
Long-Term Deferred Tax Liabilities	-	-	0.38	0.13	6.14
Other Long-Term Liabilities	34.73	37.46	65.07	2.52	5.12
Total Liabilities	191.91	200.06	218.46	186.88	300.14
Common Stock	0.04	0.03	0.03	0.03	0.03
Additional Paid-In Capital	206.54	177.81	174.28	167.35	165.53
Retained Earnings	-205.24	-166.52	-178.54	-78.97	38.58
Comprehensive Income & Other	-	-	-	-0.59	-1.36
Total Common Equity	1.34	11.32	-4.23	87.82	202.78
Shareholders' Equity	47.43	53.9	35.09	87.82	202.78
Total Liabilities & Equity	239.34	253.96	253.55	274.7	502.92
Total Debt	130.82	128.63	112.62	150.2	217.6
Net Cash (Debt)	-122.56	-120.17	-93.53	-149.21	-216.44
Net Cash Per Share	-3.52	-3.28	-3.12	-5.06	-7.39
Filing Date Shares Outstanding	37.41	30.9	30.55	29.6	29.46
Total Common Shares Outstanding	37.03	30.56	30.32	29.51	29.33
Working Capital	55.5	42.16	54.59	-59.91	46.43
Book Value Per Share	0.04	0.37	-0.14	2.98	6.91
Tangible Book Value	-16.75	-6.77	-22.31	69.74	143.24
Tangible Book Value Per Share	-0.45	-0.22	-0.74	2.36	4.88
Land	3.74	3.74	3.74	3.71	3.67
Buildings	63.73	62.87	56.79	54.56	47.88
Machinery	71.19	70.93	77.36	72.55	74.35
Construction In Progress	42.23	39.15	45.59	26.89	31.38
Leasehold Improvements	-	-	4.02	4.02	6.47

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q